Evidence map›Paper›PMID 34120207›Full record

ReviewAbdominal radiology (New York)2021

LI-RADS treatment response assessment of combination locoregional therapy for HCC.

Marielia Gerena, Christopher Molvar, Mark Masciocchi, Sadhna Nandwana, Carl Sabottke, Bradley Spieler, Rishi Sharma, Leo Tsai, Ania Kielar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marielia GerenaDepartment of Radiology and Medical Imaging, Loyola University Medical Center, Maywood, IL, USA. marielia@yahoo.com.ORCID http://orcid.org/0000-0001-8330-1682
Christopher MolvarDepartment of Radiology and Medical Imaging, Vascular and Interventional Radiology, Loyola University Medical Center, Maywood, IL, USA.ORCID http://orcid.org/0000-0002-1201-4026
Mark MasciocchiDepartment of Radiology, University of Massachusetts, Worcester, MA, USA.ORCID http://orcid.org/0000-0003-2960-357X
Sadhna NandwanaDepartment of Radiology, Abdominal Imaging and Interventions, Emory University School of Medicine, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-3021-3715
Carl SabottkeDepartment of Medical Imaging, Arizona College of Medicine, Tucson, AZ, USA.ORCID http://orcid.org/0000-0003-2176-0845
Bradley SpielerDepartment of Radiology, Louisiana State University Health Science Center, New Orleans, LA, USA.ORCID http://orcid.org/0000-0002-7346-2885
Rishi SharmaDepartment of Radiology, University of Illinois College of Medicine at Chicago , Chicago, IL, USA.ORCID http://orcid.org/0000-0003-3757-0368
Leo TsaiDepartment of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6941-7443
Ania KielarJoint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-6887-5266

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HCC incidence continues to increase worldwide and is most frequently discovered at an advanced stage when limited curative options are available. Combination locoregional therapies have emerged to improve patient survival and quality of life or downstage patients to curative options. The increasing options for locoregional therapy combinations require an understanding of the expected post-treatment imaging appearance in order to assess treatment response. This review aims to describe the synergy between TACE combined with thermal ablation and TACE combined with SBRT. We will also illustrate expected imaging findings that determine treatment efficacy based on the mechanism of tissue injury using the LI-RADS Treatment Response Algorithm.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsContrast MediaHumansMagnetic Resonance ImagingQuality of LifeRetrospective StudiesContrast MediaArterial phase hyperenhancementCombination locoregional therapyHepatocellular carcinomaLI-RADS Treatment Response AssessmentSBRTTACEThermal ablation

Identifiers

PMID34120207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.